Company Profiles

driven by the PitchBook Platform

NanoBio

Description

Operator of a biopharmaceutical company. The company develops intranasal and intramuscular vaccines focusing on respiratory, sexually transmitted and other diseases.

2000

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$1.8M

Latest Deal Amount

$70.7M

Total Amount Raised

Description

Operator of a biopharmaceutical company. The company develops intranasal and intramuscular vaccines focusing on respiratory, sexually transmitted and other diseases.

Website:

www.nanobio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Other Industries

Therapeutic Devices

Primary Office

2311 Green Road Suite A Ann Arbor, MI 48105United States +1 (734) 302-4000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NanoBio's full profile, request a free trial.

NanoBio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NanoBio Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NanoBio Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Centre Lane PartnersPE/BuyoutMinority000 0000000 0000
Lawrence BlackAngel (individual)Minority000 0000000 0000
Michigan Investment in New Technology StartupsVenture CapitalMinority000 0000000 0000
National Institute of HealthOtherMinority000 0000000 0000
North Coast Technology InvestorsVenture CapitalMinority000 0000000 0000
Centre Lane Partners PE/Buyout
Lawrence Black Angel (individual)
Michigan Investment in New Technology Startups Venture Capital
National Institute of Health Other
North Coast Technology Investors Venture Capital

NanoBio Executive Team (6)

NameTitleBoard
Seat
Contact
Info
David PeraltaChief Executive Officer & Board Member
Susan Ciotti Ph.DDirector, Formulations
Douglas SmithDirector, Immunology
Vira BitkoDirector, Virology
Ali Fattom Ph.DSenior Vice President, Vaccine Research & Development
David Peralta Chief Executive Officer & Board Member
Susan Ciotti Ph.D Director, Formulations
Douglas Smith Director, Immunology
Vira Bitko Director, Virology
Ali Fattom Ph.D Senior Vice President, Vaccine Research & Development

NanoBio Board Members (7)

NameRepresentingRoleSinceContact
Info
David PeraltaNanoBioChief Executive Officer & Board Member000 0000
David StoutSelfBoard Member000 0000
Gary Costley Ph.DSelfBoard Member000 0000
George AridaVenture InvestorsBoard Member000 0000
James Baker Jr.SelfCo-Founder & Board Member000 0000
David Peralta Chief Executive Officer & Board Member NanoBio
David Stout Board Member Self
Gary Costley Ph.D Board Member Self
George Arida Board Member Venture Investors
James Baker Jr. Co-Founder & Board Member Self
Request full access to PitchBook